|
PPP4R2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.51400000314439E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.89670004544251E-09 |
| Normal-vs-Stage2 |
1.224100E-03 |
| Normal-vs-Stage3 |
7.016800E-03 |
| Normal-vs-Stage4 |
1.52239999999804E-05 |
| Stage1-vs-Stage2 |
9.034800E-01 |
| Stage1-vs-Stage3 |
2.974800E-01 |
| Stage1-vs-Stage4 |
5.182000E-01 |
| Stage2-vs-Stage3 |
5.252200E-01 |
| Stage2-vs-Stage4 |
4.845600E-01 |
| Stage3-vs-Stage4 |
2.414800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76990000433364E-08 |
| Normal-vs-AfricanAmerican |
1.42410000014692E-07 |
| Normal-vs-Asian |
1.115530E-03 |
| Caucasian-vs-AfricanAmerican |
6.869800E-01 |
| Caucasian-vs-Asian |
6.743200E-01 |
| AfricanAmerican-vs-Asian |
7.443800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.91979987462787E-10 |
| Normal-vs-Female |
3.373800E-02 |
| Male-vs-Female |
4.412400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.72353999999819E-05 |
| Normal-vs-Extreme_Weight |
1.78819958840393E-10 |
| Normal-vs-Obese |
5.96069999999616E-05 |
| Normal-vs-Extreme_Obese |
4.311800E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.327200E-01 |
| Normal_Weight-vs-Obese |
3.318000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.789800E-01 |
| Extreme_Weight-vs-Obese |
2.353800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.655000E-01 |
| Obese-vs-Extreme_Obese |
6.808600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.078000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.55460000007236E-07 |
| Normal-vs-Age(61-80Yrs) |
1.31669997127659E-09 |
| Normal-vs-Age(81-100Yrs) |
4.74419999951792E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.035800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.991500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.892500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.077160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.187840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.033400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.67049945992903E-10 |
| Normal-VS-Type2 PRCC |
1.10149999998921E-06 |
| Normal-VS-KIRP CIMP |
9.454600E-01 |
| Normal-VS-Unclassified PRCC |
1.047800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.845000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.799500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.127800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.982100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.429400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.908410E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.8828000269977E-09 |
| Normal-vs-N1 |
3.105800E-02 |
| Normal-vs-N2 |
8.760900E-04 |
| N0-vs-N1 |
1.698010E-02 |
| N0-vs-N2 |
8.771800E-01 |
| N1-vs-N2 |
2.862400E-01 |
|
|
